Expression of Activation Induced Cytidine Deaminase and Risk of Transformation in Follicular Lymphoma
Demographics (4)
- age_grp - Age group (phv00498405.v1.p1)
- dx_age - Biological age at disease onset (phv00498404.v1.p1)
- gender - Biological sex (phv00498403.v1.p1)
- SEX - Biological sex (phv00498399.v1.p1)
Other (23)
- ANALYTE_TYPE - DNA (phv00498420.v1.p1)
- BCL2_nonsyn20 - Bcl2 nonsynonymous mutations with allele frequency > 20% (phv00498411.v1.p1)
- BODY_SITE - Body site (phv00498419.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00498398.v1.p1)
- efs_stat - Event free survival status (phv00498416.v1.p1)
- flipi - FLIPI=Follicular Lymphoma International Prognostic Index (FLIPI) (phv00498410.v1.p1)
- flipi_grp - FLIPI group (phv00498408.v1.p1)
- fu_stat - Disease follow up status (phv00498414.v1.p1)
- gelf_prima - Gelf score=Groupe d'Etude des Lymphomes Folliculaires (GELF) Criteria (phv00498407.v1.p1)
- HISTOLOGICAL_TYPE - Histological type (phv00498422.v1.p1)
- IS_TUMOR - Tumor status (phv00498421.v1.p1)
- prim_cod - Primary cause of death (phv00498413.v1.p1)
- SAMPLE_ID - Sample ID (phv00498418.v1.p1)
- SAMPLE_ID - Sample ID (phv00498401.v1.p1)
- SEQUENCING_CENTER - Sequencing center (phv00498423.v1.p1)
- stage_grp - Follicular Disease Staging (phv00498406.v1.p1)
- SUBJECT_ID - Subject ID (phv00498402.v1.p1)
- SUBJECT_ID - Subject ID (phv00498397.v1.p1)
- SUBJECT_ID - Subject ID (phv00498400.v1.p1)
- t_efs_mth - Time of event free survival in months (phv00498417.v1.p1)
- t_fu_mth - Time of follow up (survival) from initial diagnosis in months (phv00498415.v1.p1)
- trt_grp_fl1 - Treatment group (phv00498409.v1.p1)
- tx_stat - Treatment status (phv00498412.v1.p1)